Viewing StudyNCT00383929



Ignite Creation Date: 2024-05-05 @ 5:05 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00383929
Status: COMPLETED
Last Update Posted: 2008-03-20
First Post: 2006-10-03

Brief Title: Antihypertensive Efficacy and Safety of CandesartanHCT 32125 and 3225 mg in Comparison With Candesartan 32 mg
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Hypertension
Keywords:
Name View
hydrochlorothiazide View
Blood pressure reduction View
combination therapy View
candesartan cilexetil View